familial amyloid polyneuropathy

source: pixabay.com

Phase 3 International Trial for Transthyretin Amyloid Cardiomyopathy is Fully Enrolled

Post author:Trudy Horsting
Post published:June 25, 2021
Post category:Amyloidosis Hereditary ATTR Amyloidosis

Researchers have just announced that they have completed enrollment for a new Phase 3 trial for patients with transthyretin-mediated (ATTR) amyloidosis who have heart disease. This trial is examining a…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More